Celularity (CELUW) Other Non-Current Assets (2018 - 2025)
Celularity (CELUW) reported Other Non-Current Assets of $10.2 million for Q4 2025, little changed year-over-year from $10.2 million in Q4 2024, and up 4535.0% quarter-over-quarter from $220000.0 in Q3 2025.
Celularity (CELUW) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Other Non-Current Assets data on file, last reported at $10.2 million in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $10.2 million, changed 0.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.2 million (changed 0.41% YoY), and the FY2025 annual result was $10.2 million, changed 0.41% from the prior year.
- Other Non-Current Assets advanced to $10.2 million in Q4 2025 per CELUW's latest filing, from $220000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $14.8 million in Q3 2022 and troughed at $220000.0 in Q3 2025.
- A 5-year average of $5.0 million and a median of $580000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 4089.83% in 2022, then sank 97.94% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $355000.0 in 2021, then gained by 5.92% to $376000.0 in 2022, then dropped by 10.37% to $337000.0 in 2023, then surged by 2938.28% to $10.2 million in 2024, then declined by 0.41% to $10.2 million in 2025.
- Business Quant data shows CELUW's Other Non-Current Assets at $10.2 million in Q4 2025, $220000.0 in Q3 2025, and $242000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | 10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.20 Mn |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | 242,000.00 |
| Mar 31, 2025 | 10.01 Mn |
| Dec 31, 2024 | 10.24 Mn |
| Sep 30, 2024 | 287,000.00 |
| Jun 30, 2024 | 305,000.00 |
| Mar 31, 2024 | 10.05 Mn |
| Dec 31, 2023 | 337,000.00 |
| Sep 30, 2023 | 354,000.00 |
| Jun 30, 2023 | 14.83 Mn |
| Mar 31, 2023 | 14.83 Mn |
| Dec 31, 2022 | 376,000.00 |
| Sep 30, 2022 | 14.83 Mn |
| Jun 30, 2022 | 784,000.00 |
| Mar 31, 2022 | 810,000.00 |
| Dec 31, 2021 | 355,000.00 |
| Sep 30, 2021 | 354,000.00 |
| Dec 31, 2020 | 481,000.00 |
| Dec 31, 2018 | 149,750.00 |